Does Menopause Affect Outcomes from Roux-en-Y Gastric Bypass Surgery?

Estradiol increases body weight loss and satiation effects of Roux-en-Y gastric bypass (RYGB) in ovariectomized rats, according to the August issue of Gastroenterology.

Approximately ~85% of bariatric surgery procedures are performed on women, but little is known about the effects of menopause or reproductive hormones, such as estrogen, on outcomes.

Lori Asarian et al. performed RYGB surgeries on female rats that had been fattened for 3 weeks on a high-energy diet and then had their ovaries removed, to model menopause. The rats were then placed on varying diets and some were given physiologic amounts of estradiol (a form of estrogen).

The authors found that the estradiol significantly increased the ability of RYGB to reduce food intake and body weight gain, independently of what type of diet the rats were offered after the surgery (see figure).

Body weight (top) and food intake (bottom) following RYGB or a sham operation in ovariectomized rats given estradiol (E2) or oil (as a control). Significant differences were observed in SHAM-OIL vs RYGB-OIL (#); RYGB-OIL vs RYGB-E2 (*); and SHAM-OIL vs SHAM-E2 (+).

They also provided evidence that estrogen increased the satiating effects of the intestinal hormones glucagon-like peptide 1 (GLP-1, which stimulates insulin secretion and makes people feel full) and cholecystokinin (which causes release of digestive enzymes and suppresses hunger).

Asarian et al. concluded that RYGB surgery might be more effective for healthy pre-menopausal women (or post-menopausal women who receive hormone replacement therapy) than women with lower levels of estrogen.

It is not clear whether estrogens promote the effects of RYGB by the same mechanisms by which they contribute to the normal control of eating and body weight. Further experiments are also needed to determine whether estrogens affect outcomes from other types of bariatric surgeries, such as gastric banding or gastric sleeve resection.

Read the article online.
Asarian L, Abegg K, Geary N, et al. Estradiol increases body weight loss and gut-peptide satiation after roux-en-y gastric bypass in ovariectomized rats. Gastroenterology 2012;143:325–327.e2.

About Kristine Novak, PhD, Science Editor

Dr. Kristine Novak is the science editor for Gastroenterology and Clinical Gastroenterology and Hepatology, both published by the American Gastroenterological Association. She has worked as an editor at biomedical research journals and as a science writer for more than 12 years, covering advances in gastroenterology, hepatology, cancer, immunology, biotechnology, molecular genetics, and clinical trials. She has a PhD in cell biology and an interest in all areas of medical research.
This entry was posted in GI Tract, Technology and tagged , , , , , , , , , , . Bookmark the permalink.

3 Responses to Does Menopause Affect Outcomes from Roux-en-Y Gastric Bypass Surgery?

  1. ajay gunshettiwar chandrapur india says:

    Vomiting with blood for last 6 month

  2. Cheryl Pitts says:

    I am almost 50 and am entering menopause I had Roux-en-Y gastric bypass surgery almost 10 years ago. I have kept the weight off but am experiencing flushness in my face and hands is this normal affects from hot flashes as you enter menopause? I can feel swealing in my nose and mouth and hands just prior to turning bright red! This is embarassing but not sure if I need to be concerned or if normal. Can I get more info please?

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s